This adjustment accompanies the firm's reiteration of a Buy rating for the stock. The coverage transition from the Precision Team to the Healthcare Team at Jefferies is reflective of Olympus ...
(NASDAQ: ACLX) shares, raising it to $122 from the previous $83 while maintaining a "Buy" rating on the stock. The revision comes amid discussions on the safety of BCMA-CAR-T therapies ...
Stifel, a financial services firm, raised its price target on shares of IBM (NYSE:IBM) to $246 from the previous target of $205, while keeping a Buy rating on the stock. The firm's analyst noted IBM's ...